CLNINDIA · NSE: CLNINDIA · BSE: 506390
Q4 FY22 results · Jan–Mar 2022
CLNINDIA reported revenue from operations of ₹210.06 crore (down 4.0% from Q4 FY21) and net profit of ₹16.20 crore (up 47.7% from Q4 FY21) for Q4 FY22 (Jan–Mar 2022), on a standalone basis.
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 210.06 | 218.84 | −4.0% | 221.81 | −5.3% |
| Other income | 1.30 | 4.61 | −71.8% | 0.18 | +622.2% |
| Total income | 211.36 | 223.45 | −5.4% | 221.99 | −4.8% |
| Profit before tax | 12.45 | 22.74 | −45.3% | 11.47 | +8.5% |
| Net profit for the period | 16.20 | 10.97 | +47.7% | 8.45 | +91.7% |
| EPS, basic (₹) | 7.02 | 4.75 | +47.8% | 3.66 | +91.8% |
| Net margin (%) | 7.7 | 5.0 | 3.8 |
Standalone
- Filed with BSE
- 03 Jun 2022, 12:48 IST
- Board meeting
- 24 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE